Verrica Pharmaceuticals Inc. SEC filings VRCA
Verrica Pharmaceuticals Inc. has 534 filings in SEC EDGAR's recent list, going back to Dec 17, 2015. Its latest annual report, Form ARS, was filed on Apr 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Aug 18, 2026 | Aug 17, 2026 |
| 4 | Insider transaction | Aug 18, 2026 | Aug 14, 2026 |
| 4 | Insider transaction | Aug 18, 2026 | Aug 17, 2026 |
| 4 | Insider transaction | Aug 18, 2026 | Aug 18, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 9, 2026 | Jun 5, 2026 |
| S-8 | Employee stock plan registration | May 12, 2026 | — |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| ARS | Annual report to shareholders | Apr 20, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 20, 2026 | — |
| DEF 14A | Proxy statement | Apr 20, 2026 | Jun 5, 2026 |
| 10-K | Annual report | Mar 11, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2026 | Mar 11, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| 3/A | Filing | Feb 2, 2026 | Nov 25, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 29, 2026 | — |
| 3 | Initial insider ownership | Jan 26, 2026 | Nov 25, 2025 |
| 4 | Insider transaction | Dec 30, 2025 | Dec 23, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Dec 30, 2025 | — |
| 3 | Initial insider ownership | Dec 30, 2025 | Dec 26, 2025 |
| 3 | Initial insider ownership | Dec 30, 2025 | Dec 26, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 30, 2025 | Dec 23, 2025 |
| EFFECT | Filing | Dec 23, 2025 | — |
| 424B3 | Prospectus | Dec 23, 2025 | — |
| CORRESP | Letter to the SEC | Dec 19, 2025 | — |
| S-3 | Shelf registration | Dec 15, 2025 | — |
| D | Filing | Dec 10, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 3, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 28, 2025 | — |
| 4 | Insider transaction | Nov 25, 2025 | Nov 25, 2025 |
| 4 | Insider transaction | Nov 25, 2025 | Nov 25, 2025 |
| 4 | Insider transaction | Nov 25, 2025 | Nov 25, 2025 |
| 4 | Insider transaction | Nov 25, 2025 | Nov 25, 2025 |
| 4 | Insider transaction | Nov 25, 2025 | Nov 25, 2025 |
| SCHEDULE 13D | Ownership over 5% (active) | Nov 24, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Nov 24, 2025 | Nov 23, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2025 | Nov 14, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 12, 2025 | Aug 8, 2025 |
| 8-K |
Current report
Listing notice
|
Jul 30, 2025 | Jul 24, 2025 |
| 8-K |
Current report
Change to shareholder rights
|
Jul 23, 2025 | Jul 22, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 1, 2025 | Jun 27, 2025 |
| 8-K |
Current report
Material agreement
|
Jun 12, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2025 | Jun 5, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| S-8 | Employee stock plan registration | May 13, 2025 | — |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| DEFR14A | Filing | Apr 30, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Apr 25, 2025 | Apr 22, 2025 |
| ARS | Annual report to shareholders | Apr 22, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 22, 2025 | — |
| DEF 14A | Proxy statement | Apr 22, 2025 | Jun 5, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 11, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 3 | Initial insider ownership | Apr 2, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Mar 26, 2025 | Mar 24, 2025 |
| 3 | Initial insider ownership | Mar 26, 2025 | Mar 24, 2025 |
| EFFECT | Filing | Mar 25, 2025 | — |
| CORRESP | Letter to the SEC | Mar 21, 2025 | — |
| 4 | Insider transaction | Mar 18, 2025 | Mar 14, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 14, 2025 |
| UPLOAD | Letter from the SEC | Mar 17, 2025 | — |
| S-3 | Shelf registration | Mar 11, 2025 | — |
| 10-K | Annual report | Mar 11, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2025 | Mar 11, 2025 |
| 8-K |
Current report
Material agreement
|
Feb 21, 2025 | Feb 18, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 12, 2025 | — |
| 4/A | Filing | Feb 6, 2025 | Aug 24, 2023 |
| 4/A | Filing | Feb 6, 2025 | Aug 24, 2023 |
| 4/A | Filing | Feb 6, 2025 | Aug 24, 2023 |
| 4/A | Filing | Feb 6, 2025 | Aug 24, 2023 |
| 4/A | Filing | Feb 6, 2025 | Aug 24, 2023 |
| 8-K |
Current report
Listing notice
|
Jan 30, 2025 | Jan 24, 2025 |
| SC 13G/A | Amended ownership over 5% (passive) | Dec 9, 2024 | — |
| 4 | Insider transaction | Dec 9, 2024 | Dec 9, 2024 |
| 3 | Initial insider ownership | Dec 9, 2024 | Dec 9, 2024 |
| S-8 | Employee stock plan registration | Dec 9, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Dec 9, 2024 | Dec 4, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Nov 26, 2024 | — |
| 4 | Insider transaction | Nov 26, 2024 | Nov 22, 2024 |
| 4 | Insider transaction | Nov 26, 2024 | Nov 22, 2024 |
| 4 | Insider transaction | Nov 26, 2024 | Nov 22, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 21, 2024 | Nov 20, 2024 |
| 424B5 | Prospectus supplement | Nov 21, 2024 | — |
| 8-K |
Current report
Other events
|
Nov 20, 2024 | Nov 20, 2024 |
| 424B5 | Prospectus supplement | Nov 20, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 4 | Insider transaction | Nov 6, 2024 | Nov 6, 2024 |
| 3 | Initial insider ownership | Nov 6, 2024 | Nov 5, 2024 |
| 4 | Insider transaction | Nov 6, 2024 | Nov 6, 2024 |
| 3 | Initial insider ownership | Nov 6, 2024 | Nov 5, 2024 |
| S-8 | Employee stock plan registration | Nov 6, 2024 | — |
| 10-Q | Quarterly report | Nov 5, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Nov 4, 2024 | Nov 1, 2024 |
| 4 | Insider transaction | Oct 11, 2024 | Oct 9, 2024 |
| 8-K |
Current report
Listing notice, Officer or director change
|
Oct 8, 2024 | Oct 2, 2024 |
| 8-K |
Current report
Exit or restructuring costs
|
Oct 1, 2024 | Oct 1, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 27, 2024 | Sep 23, 2024 |
| 4 | Insider transaction | Sep 23, 2024 | Sep 19, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 6, 2024 | Aug 30, 2024 |
| 4 | Insider transaction | Aug 28, 2024 | Aug 26, 2024 |
| 4 | Insider transaction | Aug 28, 2024 | Aug 26, 2024 |
| 4 | Insider transaction | Aug 28, 2024 | Aug 26, 2024 |
| 4 | Insider transaction | Aug 28, 2024 | Aug 26, 2024 |
| 4 | Insider transaction | Aug 28, 2024 | Aug 26, 2024 |
| 8-K |
Current report
Officer or director change
|
Aug 27, 2024 | Aug 21, 2024 |
| 144 | Notice of proposed sale | Aug 26, 2024 | — |
| 144 | Notice of proposed sale | Aug 26, 2024 | — |
| 144 | Notice of proposed sale | Aug 26, 2024 | — |
| 144 | Notice of proposed sale | Aug 26, 2024 | — |
| 144 | Notice of proposed sale | Aug 26, 2024 | — |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 14, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Material agreement
|
Aug 5, 2024 | Aug 2, 2024 |
| 4 | Insider transaction | Jul 23, 2024 | Jul 22, 2024 |
| 4 | Insider transaction | Jul 23, 2024 | Jul 22, 2024 |
| 4 | Insider transaction | Jul 23, 2024 | Jul 22, 2024 |
| 4 | Insider transaction | Jul 23, 2024 | Jul 22, 2024 |
| 144 | Notice of proposed sale | Jul 22, 2024 | — |
| 144 | Notice of proposed sale | Jul 22, 2024 | — |
| 144 | Notice of proposed sale | Jul 22, 2024 | — |
| 144 | Notice of proposed sale | Jul 22, 2024 | — |
| 8-K |
Current report
Material agreement
|
Jun 28, 2024 | Jun 26, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 6, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
May 15, 2024 | May 14, 2024 |
| S-8 | Employee stock plan registration | May 13, 2024 | — |
| 10-Q | Quarterly report | May 13, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 13, 2024 | May 13, 2024 |
| ARS | Annual report to shareholders | Apr 19, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 19, 2024 | — |
| DEF 14A | Proxy statement | Apr 19, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Mar 19, 2024 | Mar 15, 2024 |
| 4 | Insider transaction | Mar 19, 2024 | Mar 15, 2024 |
| 4 | Insider transaction | Mar 19, 2024 | Mar 15, 2024 |
| 4 | Insider transaction | Mar 19, 2024 | Mar 15, 2024 |
| 4 | Insider transaction | Mar 19, 2024 | Mar 15, 2024 |
| 10-K | Annual report | Feb 29, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 29, 2024 | Feb 29, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| 4 | Insider transaction | Dec 29, 2023 | Dec 27, 2023 |
| 4 | Insider transaction | Dec 26, 2023 | Dec 21, 2023 |
| 4 | Insider transaction | Dec 19, 2023 | Dec 15, 2023 |
| 4 | Insider transaction | Nov 16, 2023 | Nov 14, 2023 |
| 4 | Insider transaction | Nov 16, 2023 | Nov 14, 2023 |
| 4 | Insider transaction | Nov 16, 2023 | Nov 14, 2023 |
| 4 | Insider transaction | Nov 16, 2023 | Nov 14, 2023 |
| 4 | Insider transaction | Nov 16, 2023 | Nov 14, 2023 |
| 144/A | Filing | Nov 16, 2023 | — |
| 144 | Notice of proposed sale | Nov 15, 2023 | — |
| 144 | Notice of proposed sale | Nov 15, 2023 | — |
| 144 | Notice of proposed sale | Nov 15, 2023 | — |
| 144 | Notice of proposed sale | Nov 15, 2023 | — |
| 144 | Notice of proposed sale | Nov 15, 2023 | — |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 4 | Insider transaction | Aug 28, 2023 | Aug 24, 2023 |
| 4 | Insider transaction | Aug 28, 2023 | Aug 24, 2023 |
| 4 | Insider transaction | Aug 28, 2023 | Aug 24, 2023 |
| 4 | Insider transaction | Aug 28, 2023 | Aug 24, 2023 |
| 4 | Insider transaction | Aug 28, 2023 | Aug 24, 2023 |
| 10-Q | Quarterly report | Aug 8, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 27, 2023 | Jul 27, 2023 |
| 144 | Notice of proposed sale | Jul 27, 2023 | — |
| 144 | Notice of proposed sale | Jul 27, 2023 | — |
| 144 | Notice of proposed sale | Jul 27, 2023 | — |
| 144 | Notice of proposed sale | Jul 27, 2023 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Jul 26, 2023 | Jul 26, 2023 |
| 4 | Insider transaction | Jul 25, 2023 | Jul 21, 2023 |
| 4 | Insider transaction | Jul 25, 2023 | Jul 21, 2023 |
| 4 | Insider transaction | Jul 25, 2023 | Jul 21, 2023 |
| 4 | Insider transaction | Jul 25, 2023 | Jul 21, 2023 |
| 4 | Insider transaction | Jul 24, 2023 | Jul 24, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VRCA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- West Chester, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1660334
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.